Tech Company Financing Transactions

Slate Medicines Funding Round

Slate Medicines closed a $130 million Series A funding round on 2/24/2026. Backers included Forbion Capital Partners, Foresite Capital and RA Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

200 Berkeley Street, 18th Floor
Boston, MA 02116
USA

Phone

(919) 541-9366

Website

www.slatemedicines.com

Email Address

Not Recorded

Overview

Slate Medicines is a biotechnology company focused on developing next generation therapeutics targeting PACAP for the treatment and prevention of migraine and other headache disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Oakes

        

Browse more venture capital transactions:

Prev: 2/24/2026: Kash venture capital transaction
Next: 2/24/2026: MatX venture capital transaction

Share this article

Where The Data Comes From

We do our best to record funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary